CPhI-ChinaMarch 06, 2018
Tag: P-MEC China 2018 , CPHI China
——P-MEC China 2018 to Pass the "Year of Transformation" of Ideas together with Pharmaceutical Enterprises
The China Food and Drug Administration (CFDA) officially released the Decision of the China Food and Drug Administration to Amend Certain Rules in November 2017. After amendment of the Drug Administration Law, CFDA will uniformly amend relevant provisions on good manufacturing practice (GMP) certification and good supply practice (GSP) certification involved in the pharmaceutical product regulatory rules, and GMP and GSP certification will walk down the stage of history. This mentality transformation from "stressing threshold" to "stressing supervision" means that the production and operation of pharmaceutical enterprises will be confronted with more frequent and stricter daily supervision in the future.
At this key turning point, the P-MEC China 2018 hosted by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and co-sponsored by Shanghai UBM Sinoexpo International Exhibition Co., Ltd. (UBM Sinoexpo) will be grandly held at Shanghai New International Expo Centre on June 20-22, 2018, to serve as a bridge between advanced pharmaceutical equipment and information construction providers and terminal pharmaceutical enterprise users.
Focusing on optimization of the whole pharmaceutical production process, from front end to back end
Since the introduction of the intelligent concept in 2015, P-MEC China has been complying with the market development trends while showcasing quality production equipment, and constantly developing exhibitors in the automation and informatization fields, to bring terminal pharmaceutical enterprises the high-end technology providers that optimize the whole pharmaceutical production process. In 2018, P-MEC China will open special exhibition zones centering on "conveying, storage, and production equipment automation", and "enterprise and production management informatization" in Hall N4, where Chinese and overseas professional providers of total solutions of pharmaceutical and biological industry automatic systems represented by Beijing Chieftain Control Engineering Technology Co., Ltd. will gather, to exhibit more automatic equipment and information technologies with high reliability and stability to pharmaceutical enterprises.
Discussing the control of pharmaceutical production quality, from ideas to practice
With the increasingly frequent regular supervision as well as the special requirement in the Amendment of the Drug Administration Law of the People's Republic of China (Draft for Comment) for implementing punishment to specific person, how to build comprehensive quality culture, develop a perfect mechanism for quality risk early warning, and formulate the operation specification after occurrence of data deviation have become the key working points more and more pharmaceutical enterprises need to implement. As an important summit concurrently with the exhibition, the P-MEC China Summit 2018 will furnish the industry practitioners an excellent platform for analysis of policies and regulations, discussion of quality management system construction and data integrity requirements, and showcasing of latest technologies. Leading pharmaceutical enterprises like Tasly Pharmaceutical Group Co., Ltd., Kelun Industry Group, Suzhou Otsuka Pharmaceutical Co., Ltd., and Zhejiang Huahai Pharmaceutical Co., Ltd. have recently confirmed their participation in this summit to make speeches on relevant themes.
P-MEC China 2018 will take place again in Shanghai New International Expo Centre on June 20-22, 2018, and will welcome the colleagues in the pharmaceutical industry through constantly improving the exhibit quality, and optimizing concurrent supporting meetings and activities. The visitor pre-registration has been started. Click the link to get your free ticket!
P-MEC China has launched a new official online information platform as below where you can get the latest information, industry data, and policy interpretation in the pharmaceutical machinery industry anytime anywhere, to seize the first chances!
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: